Pharming Group NV announced the proposed election of Mr. Robin Wright as the company's new Chief Financial Officer and member of the Management Board at an Extraordinary General Meeting of shareholders, to be held on 28 October 2015. Wright will be responsible for the financial management, accounting and investor relations activities of the company within the CFO role, which has previously been undertaken by CEO, Dr. De Vries, and will serve as a member of the Board of Management. He has extensive senior level experience as a CFO of public companies in both the pharmaceutical and biotechnology industries.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8445 EUR | +2.18% | +3.68% | -18.09% |
21/05 | Transcript : Pharming Group N.V. - Shareholder/Analyst Call | |
08/05 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.09% | 604M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group NV Nominates Robin Wright as Chief Financial Officer and Member of the Management Board